http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104688672-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
filingDate 2014-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2018-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104688672-B
titleOfInvention Puerarin gel eyedrop is preparing the application in treating retinopathy medicine
abstract A kind of Puerarin gel eyedrop is preparing the application in treating retinopathy medicine, the eye drops is made up of Puerarin, EDTA, sodium pyrosulfite, borneol, benzalkonium bromide, pool Lip river yarn nurse 407, Sodium Hyaluronate, sodium citrate, citric acid and water for injection, with HPLC UV methods, proved through pharmacokinetics in rabbit eyes:Uptake of the 1.2% Puerarin gel eyedrop in retina, choroid is respectively greater than the 70% and 62% of Puerarin ordinary eye drops;By aqueous humor, the conversion of vitreum proportion, intraocular puerarin content choroid>Retina>Aqueous humor>Vitreum, disclose Puerarin and absorbed on eyeground and can reach enough contents into eyeground.It is observed that 1.2% Puerarin gel eyedrop measures the medicine average content on curve each time point in 16 hours Puerarins on rabbit retina, choroid(ng/g)Rabbit when not less than retinal haemodynamics measure effectively causes the content measured during the VPV enhancing of eyeground(ng/g);So as to confirm that Puerarin gel eyedrop can be used as intravenous puerarin for treating retinopathy.
priorityDate 2014-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID352190
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419529048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663392
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID311
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281807
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9986
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446220
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447812447
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454013444
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507876
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID352190
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448616730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416053110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556761
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86740622
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450770914
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID44681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6552009
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6224
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID44681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409206349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9986
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450254702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474445
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644017
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21863217

Total number of triples: 46.